Heart Test Laboratories-CW27HSCSWPreferred / convertible
13F holders, Q4 2024 (December 31)5holders +2
2new positions
0sold out
1famous investor
$0.03avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Heart Test Laboratories-CW27 (HSCSW) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were Clear Street LLC ($8K), Citadel Advisors ($6K) and Susquehanna International Group, LLP ($1K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Heart Test Laboratories-CW27
- Filed as
- HEARTSCIENCES INC (Q4 2024)
- CUSIP
- 42254E112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $151 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 7,631 shares bought and 6,271 shares sold, net +1,360 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Clear Street LLC | — | Add +0.3% | 270,770 | $8K |
| Citadel Advisors | — | Reduce -2.8% | 214,157 | $6K |
| Susquehanna International Group, LLP | — | Add +4.4% | 40,535 | $1K |
| Armistice Capital, LLC | — | New | 3,529 | $106 |
| UBS Group AG | — | New | 1,500 | $45 |
"% of holder's portfolio" is HSCSW's weight in each manager's 13F, not the share of Heart Test Laboratories-CW27 the manager owns.